GoodRx Holdings, Inc.

NASDAQ:GDRX

Medical - Healthcare Information Services

Healthcare
$3.36 +1.72%

+$0.05 today

Market cap
$1.15B
Beta
1.61
P/E (TTM)
44.0
EPS (TTM)
$0.06
52W Low $1.77High $5.81

Volume 0.66M

Average 1.61M

GDRX Pre-Tax Margin

Income before tax as a percentage of revenue.

GoodRx Holdings, Inc.NASDAQ: GDRX

Pre-Tax Margin · Q1 FY2026 · quarter ended Mar 2026

Pre-tax margin narrows to 2.9%

Pre-tax margin was 2.9% in Q1 FY2026, down 5.3 pp from a year earlier. On a trailing-twelve-month basis it was 5.8%, down 0.2 pp year over year. Over 3 fiscal years it widened by 10.1 pp.

Context

  • Pre-tax margin widened in 2 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
2.9%-4.4 pp QoQ
Last fiscal yearDec 2025
7.1%+3.1 pp YoY
LTMMar 2026
5.8%-0.2 pp YoY
Pre-Tax Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-5.3 pp——
1 year+3.1 pp——
3 years+10.1 pp——
5 years——
10 years——

Pre-Tax Margin history

Percent of revenue · from the income statement

Latest · FY2025
7.1%
Year-over-year change
+3.1pp

Pre-Tax Margin vs competitors

How GDRX compares with its peers on the latest reported figures

  • GDRX's LTM Mar 2026 pre-tax margin of 5.8% is the highest of the 4 companies compared; the peer median is -7.4%.
  • Its year-over-year change of -0.2 pp is the 3rd highest of 4, against a peer median of +22.8 pp.
  • Over three fiscal years its change of +10.1 pp compares with a peer median of +60.2 pp.
GDRX Competitors Peer median
Pre-Tax Margin for GDRX and competitors
Company Period LTM level YoY 3-year change
GDRXGoodRx Holdings, Inc.LTM Mar 20265.8% -0.2 pp+10.1 pp
LFMDLifeMD, Inc.LTM Mar 2026-6.8% -2.9 pp+32.3 pp
TDOCTeladoc Health, Inc.LTM Mar 2026-7.4% +32.8 pp+558.4 pp
AMWLAmerican Well CorporationLTM Mar 2026-36.6% +22.8 pp+60.2 pp
Peer median (excluding GDRX) -7.4%+22.8 pp+60.2 pp

Competitors are the stored peer set for GDRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue745.42M766.55M750.27M792.32M796.85M
Cost of Revenue46.72M65.08M66.93M48.22M57.6M
Gross Profit698.71M701.48M683.34M744.11M739.26M
Gross Margin93.7%91.5%91.1%93.9%92.8%
Research & Development125.86M143.14M135.84M123.75M121.03M
Selling, General & Admin524.9M502.42M466.84M484.98M445.52M
Operating Expenses685.3M699.74M710.35M678.26M651.76M
Depreciation & Amortization34.54M54.18M107.67M69.54M85.22M
EBITDA48M65.19M108.82M153.92M184.36M
EBITDA Margin6.4%8.5%14.5%19.4%23.1%
Operating Income13.41M1.74M(27.01M)65.85M87.49M
Operating Margin1.8%0.2%-3.6%8.3%11.0%
Interest Income59K9.27M32.17M23.27M10.93M
Interest Expense23.64M34.24M56.73M52.92M42.61M
Other Income / Expenses(23.58M)(24.97M)(28.57M)(34.39M)(30.95M)
Income Before Tax(10.18M)(23.23M)(55.57M)31.46M56.54M
Pre-Tax Margin-1.4%-3.0%-7.4%4.0%7.1%
Income Tax Expense15.08M9.6M(46.7M)15.07M26.1M
Net Income(25.25M)(32.83M)(8.87M)16.39M30.44M
Net Margin-3.4%-4.3%-1.2%2.1%3.8%
EPS (Basic)(0.06)(0.08)(0.02)0.040.09
EPS (Diluted)(0.06)(0.08)(0.02)0.040.09
Weighted Avg Shares409.98M412.86M410.32M385.74M356.33M
Weighted Avg Shares (Diluted)409.98M412.86M410.32M392.17M356.97M

GoodRx Holdings, Inc.

NASDAQ:GDRX

Intrinsic Alpha fair value

Locked

Current Price

$3.36

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.